What is Rapport Therapeutics, Inc.'s total revenue?

Rapport Therapeutics, Inc. (RAPP) reported total revenue of $20M in Q1 2026.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Rapport Therapeutics, Inc. RAPP Total Revenue

Total Revenue at other companies

Bristol-Myers SquibbBMY

$11.49B+2.6%

Supernus PharmaceuticalsSUPN

$207.71M+38.6%

Xenon PharmaceuticalsXENE

$0-100%

Septerna, Inc.SEPN

$26.52M+12,011%

Taysha Gene Therapies, Inc.TSHA

$0-100%

Acadia PharmaceuticalsACAD

$268.06M+9.7%

Other financials

Income statement

See full

Operating income-$24.2M+10.7%

Net income-$19.9M+17.5%

EPS (diluted)-$0.42+38.2%

Balance sheet

See full

Cash & equivalents$78.1M+35.5%

Total debt$10.8M+37.8%

Total equity$471.5M+65.0%

Total assets$497.6M+64.7%

Cash flow

See full

Operating cash flow-$13.1M+35.5%

CapEx$86.0K-70.4%

Free cash flow-$13.1M+36.0%

Valuation

See full

Market cap$1.86B+309%

Enterprise value$1.79B+352%

Returns & leverage

See full

Return on equity-28.3%—

Debt / equity0×0.0×

Current ratio27.1×-3.9×

Where this comes from

Reported directly by Rapport Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapport Therapeutics, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rapport Therapeutics, Inc.'s total revenue?: Rapport Therapeutics, Inc. (RAPP) reported total revenue of $20M in Q1 2026.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.